Aceto Corporation
One Hollow Lane
Lake Success
New York
11042
United States
Tel: 516-627-6000
Fax: 516-627-6093
Website: http://www.aceto.com/
Email: aceto@aceto.com
132 articles about Aceto Corporation
-
Aceto Acquires Biotron Laboratories and Talus Mineral Company (Collectively “Biotron”), Leading Manufacturers of Specialty Ingredients for the Nutritional Supplements Industry
3/2/2022
Acquisition Brings 40 Years of Leadership In Applying Proprietary Processes and Expertise to the Development and Manufacture of Mineral Chelates and Other Specialty Ingredients for Nutritional Supplements.
-
Aceto Propels Growth Strategy with Cascade Chemistry Acquisition
6/2/2021
Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced the acquisition of Eugene, Oregon-based Cascade Chemistry, manufacturer of active pharmaceutical ingredients, regulatory starting materials and advanced intermediates.
-
Aceto Expands Life Science Manufacturing with Acquisition of Finar Limited
5/17/2021
Aceto , a leading global provider of specialty materials for life sciences and advanced technology end markets, announced today the acquisition of a majority stake in Finar Limited. Finar is a leading manufacturer, supplier, and distributor of pharmaceutical excipients, lab chemicals, aquaculture inputs, and food grade additives.
-
Aceto to Expand Bioreagent Offering to Support Growing Customer Demand in Biopharma and Cell Culture Manufacturing
3/15/2021
Aceto, a leading global virtual manufacturer of specialty materials for life sciences and advanced technology end markets, announced the introduction of an expanded portfolio for biopharmaceutical and cell culture reagent manufacturers.
-
Aceto Establishes Chemical Manufacturing and R&D Capabilities in the U.S. Through Acquisition of IsleChem
12/21/2020
Acquisition enhances Aceto’s ability to support customers through all stages of product development
-
Aceto Investigation: Bernstein Liebhard LLP Announces Investigation Of Aceto Corporation - ACET
9/28/2018
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Aceto Corporation ("Aceto" or the "Company") (NASDAQ: ACET) resulting from allegations that Aceto and/or its executives may have issued materially misleading business information to the investing public.
-
Aceto Subsidiary, Rising Pharma, Announces Product Launches
7/21/2017
-
Aceto Subsidiary, Rising Pharma, Launches Chlorthalidone Tablets, 25 Mg And 50 Mg, And Glipizide Extended Release Tablets, 2.5 Mg, 5 Mg And 10 Mg
6/20/2017
-
Verdezyne, Inc. Signs Distribution Agreement With Aceto
10/5/2016
-
Aceto Subsidiary, Rising Pharma, To Launch Lithium Carbonate Extended-Release Tablets And Metronidazole Tablets
3/23/2016
-
Aceto Reports Fiscal 2016 Second Quarter Results
2/5/2016
-
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, To Launch Zolmitriptan Tablets
1/25/2016
-
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, To Launch Olopatadine Hydrochloride Ophthalmic Solution
12/8/2015
-
Aceto Corporation Board Of Directors Declares Quarterly Cash Dividend
12/4/2015
-
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, To Launch Dutasteride Softgel Capsules
11/24/2015
-
Aceto Corporation Announces The Exercise In Full Of The Over-Allotment Option In Its Convertible Notes Offering
11/24/2015
-
Aceto Corporation Announces The Pricing Of Its $125 Million Convertible Notes Offering
11/11/2015
-
Aceto Corporation Schedules First Quarter & Fiscal 2016 Financial Results News Release And Conference Call
10/26/2015
-
Aceto Corporation Files Shelf Registration Statement
10/14/2015
-
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, To Launch Glycopyrrolate Tablets And Methimazole Tablets
10/2/2015